{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:53:38Z","timestamp":1793159618530,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,22]],"date-time":"2026-12-22T00:00:00Z","timestamp":1797897600000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG050515"],"award-info":[{"award-number":["R01AG050515"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jagp.2025.10.011","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T02:52:41Z","timestamp":1762829561000},"page":"167-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer\u2019s Disease"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1106-4299","authenticated-orcid":false,"given":"Paul B.","family":"Rosenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halima","family":"Amjad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Burhanullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milap","family":"Nowrangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Vandrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mersania Jn","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Outen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Marano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Agronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Laffaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eilis","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosain","family":"Ozonsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Drury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuna","family":"Haso\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Cromwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie-Marie","family":"Leoutsakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent P.","family":"Forester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jagp.2025.10.011_bib0001","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/gps.1858","article-title":"Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study","volume":"23","author":"Steinberg","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2025.10.011_bib0002","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/gps.5244","article-title":"Dementia and caregiver burden: a three-year longitudinal study","volume":"35","author":"Connors","year":"2020","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2025.10.011_bib0003","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jagp.2017.02.025","article-title":"Distress associated with dementia-related psychosis and agitation in relation to healthcare utilization and costs","volume":"25","author":"Maust","year":"2017","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2025.10.011_bib0004","first-page":"e47","volume":"10","year":"2014"},{"issue":"16","key":"10.1016\/j.jagp.2025.10.011_bib0005","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1001\/jama.287.16.2090","article-title":"Patient and caregiver characteristics and nursing home placement in patients with dementia","volume":"287","author":"Yaffe","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jagp.2025.10.011_bib0006","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1041610214001963","article-title":"Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition","volume":"27","author":"Cummings","year":"2015","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"10.1016\/j.jagp.2025.10.011_bib0007","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1017\/S1041610222001041","article-title":"Agitation in cognitive disorders: progress in the International Psychogeriatric Association consensus clinical and research definition","volume":"36","author":"Sano","year":"2024","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jagp.2025.10.011_bib0008","doi-asserted-by":"crossref","first-page":"h369","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jagp.2025.10.011_bib0009","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3233\/JAD-230116","article-title":"Effects of the DICE method to improve timely recognition and treatment of neuropsychiatric symptoms in early Alzheimer's disease at the Memory Clinic: the BEAT-IT Study","volume":"93","author":"Eikelboom","year":"2023","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.jagp.2025.10.011_bib0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"10.1016\/j.jagp.2025.10.011_bib0011","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.293.5.596","article-title":"Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence","volume":"293","author":"Sink","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jagp.2025.10.011_bib0012","article-title":"The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer\u2019s disease","volume":"1","author":"Ballard","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.jagp.2025.10.011_bib0013","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2014.93","article-title":"Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial","volume":"311","author":"Porsteinsson","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jagp.2025.10.011_bib0014","article-title":"Prazosin for the management of behavioural and psychological symptoms of dementia","volume":"11","author":"Tampi","year":"2022","journal-title":"Drugs Context"},{"key":"10.1016\/j.jagp.2025.10.011_bib0015","series-title":"Alzheimer\u2019s Association International Conference","article-title":"Efficacy and safety of AXS-05 in agitation associated with Alzheimer\u2019s Disease: results from ACCORD, a phase 3, double-blind, placebo-controlled, relapse prevention trial","author":"Cummings","year":"2024"},{"key":"10.1016\/j.jagp.2025.10.011_bib0016","series-title":"BioXcel therapeutics receives FDA breakthrough therapy designation for BXCL501 for the acute treatment of agitation associated with Dementia","year":"2021"},{"key":"10.1016\/j.jagp.2025.10.011_bib0017","series-title":"BioXcel Therapeutics announces BXCL501 met the primary and all secondary endpoints in the TRANQUILITY Phase 1b\/2 study for the acute treatment of agitation in dementia, including Alzheimer\u2019s Disease","year":"2021"},{"issue":"1","key":"10.1016\/j.jagp.2025.10.011_bib0018","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.ajp.2011.11030347","article-title":"Risk of mortality among individual antipsychotics in patients with dementia","volume":"169","author":"Kales","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"15","key":"10.1016\/j.jagp.2025.10.011_bib0019","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jagp.2025.10.011_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu Rev Psychol"},{"key":"10.1016\/j.jagp.2025.10.011_bib0021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mam.2015.05.005","article-title":"Neuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits?","volume":"43\u201344","author":"Rosenberg","year":"2015","journal-title":"Mol Aspects Med"},{"issue":"4","key":"10.1016\/j.jagp.2025.10.011_bib0022","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jagp.2012.11.022","article-title":"Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms","volume":"22","author":"Woodward","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"issue":"23","key":"10.1016\/j.jagp.2025.10.011_bib0023","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1212\/WNL.0000000000001675","article-title":"Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: a randomized controlled trial","volume":"84","author":"van den Elsen","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2025.10.011_bib0024","doi-asserted-by":"crossref","unstructured":"Rosenberg PB, Forester BP, Agronin ME, et al. Trial of dronabinol adjunctive treatment in agitation in Alzheimer\u2019s disease (AD) (THC-AD). Am J Psychiatry 28(4), S121\u2013S122","DOI":"10.1016\/j.jagp.2020.01.150"},{"issue":"12","key":"10.1016\/j.jagp.2025.10.011_bib0025","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1017\/S1041610221001150","article-title":"Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's dementia (THC-AD)","volume":"36","author":"Cohen","year":"2024","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jagp.2025.10.011_bib0026","first-page":"263","volume":"7","author":"McKhann","year":"2011"},{"issue":"12","key":"10.1016\/j.jagp.2025.10.011_bib0027","doi-asserted-by":"crossref","first-page":"941","DOI":"10.7326\/0003-4819-113-12-941","article-title":"Clarifying confusion: the confusion assessment method. A new method for detection of delirium","volume":"113","author":"Inouye","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jagp.2025.10.011_bib0028","unstructured":"American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, American Psychiatric Association; Washington, DC."},{"issue":"8","key":"10.1016\/j.jagp.2025.10.011_bib0047","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/sim.1384","article-title":"Sample size estimation for GEE method for comparing slopes in repeated measurements data","volume":"22","author":"Jung","year":"2003","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.jagp.2025.10.011_bib0029","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0197-2456(02)00242-8","article-title":"The method of minimization for allocation to clinical trials. A review","volume":"23","author":"Scott","year":"2002","journal-title":"Control Clin Trials"},{"issue":"1","key":"10.1016\/j.jagp.2025.10.011_bib0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00019442-199400210-00008","article-title":"A user-friendly instrument for rating agitation in dementia patients","volume":"2","author":"Rosen","year":"1994","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"10.1016\/j.jagp.2025.10.011_bib0031","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","article-title":"Intraclass correlations: uses in assessing rater reliability","volume":"86","author":"Shrout","year":"1979","journal-title":"Psychol Bull"},{"issue":"6","key":"10.1016\/j.jagp.2025.10.011_bib0032","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1017\/S1041610210000876","article-title":"The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia","volume":"22","author":"de Medeiros","year":"2010","journal-title":"Int Psychogeriatr"},{"issue":"12","key":"10.1016\/j.jagp.2025.10.011_bib0033","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1016\/j.jagp.2025.10.011_bib0034","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer\u2019s disease. The Alzheimer\u201ds Disease Cooperative Study","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"Suppl 3","key":"10.1016\/j.jagp.2025.10.011_bib0035","first-page":"309","article-title":"Conceptualization of agitation: results based on the Cohen-Mansfield agitation inventory and the agitation behavior mapping instrument","volume":"8","author":"Cohen-Mansfield","year":"1996","journal-title":"Int Psychogeriatr"},{"issue":"10","key":"10.1016\/j.jagp.2025.10.011_bib0036","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1532-5415.1986.tb04302.x","article-title":"Agitated behaviors in the elderly. I. A conceptual review","volume":"34","author":"Cohen-Mansfield","year":"1986","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.jagp.2025.10.011_bib0039","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jagp.2021.01.015","article-title":"Cannabinoids for agitation in Alzheimer's disease","volume":"29","author":"Outen","year":"2021","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2)","key":"10.1016\/j.jagp.2025.10.011_bib0037","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability of the Alzheimer's disease cooperative study-clinical global impression of change. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Schneider","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jagp.2025.10.011_bib0040","series-title":"Stata Statistical Software: Release 13","year":"2013"},{"key":"10.1016\/j.jagp.2025.10.011_bib0041","series-title":"R: a Language and Environment for Statistical Computing","year":"2013"},{"key":"10.1016\/j.jagp.2025.10.011_bib0042","first-page":"121","volume":"42","author":"Zeger","year":"1986"},{"issue":"7","key":"10.1016\/j.jagp.2025.10.011_bib0045","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1041610217000151","article-title":"Clinical evaluation of brief cognitive assessment measures for patients with severe dementia","volume":"29","author":"Dixon","year":"2017","journal-title":"Int Psychogeriatr"},{"issue":"6","key":"10.1016\/j.jagp.2025.10.011_bib0046","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/JGP.0b013e3181faec23","article-title":"Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression Study","volume":"19","author":"Tschanz","year":"2011","journal-title":"Am J Geriatr Psychiatry"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748125005068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748125005068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:11:54Z","timestamp":1777097514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748125005068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1064748125005068"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2025.10.011","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2025.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}